Asset Details
Do you wish to reserve the book?
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
Do you wish to request the book?
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
2022
Overview
Ovarian cancer (OC) is the fifth leading cause of women’s death from cancers. The high mortality rate is attributed to the late presence of the disease and the lack of modern diagnostic tools, including molecular biomarkers. Moreover, OC is a highly heterogeneous disease, which contributes to early treatment failure. Thus, exploring OC molecular mechanisms could significantly enhance our understanding of the disease and provide new treatment options. Chromatin remodeling complexes (CRCs) are ATP-dependent molecular machines responsible for chromatin reorganization and involved in many DNA-related processes, including transcriptional regulation, replication, and reparation. Dysregulation of chromatin remodeling machinery may be related to cancer development and chemoresistance in OC. Some forms of OC and other gynecologic diseases have been associated with mutations in specific CRC genes. Most notably, ARID1A in endometriosis-related OC, SMARCA4, and SMARCB1 in hypercalcemic type small cell ovarian carcinoma (SCCOHT), ACTL6A, CHRAC1, RSF1 amplification in high-grade serous OC. Here we review the available literature on CRCs’ involvement in OC to improve our understanding of its development and investigate CRCs as possible biomarkers and treatment targets for OC.
Publisher
MDPI AG,MDPI
Subject
/ Carcinoma, Ovarian Epithelial
/ Chromatin Assembly and Disassembly
/ DNA-Binding Proteins - metabolism
/ Female
/ Genes
/ Humans
/ Mutation
/ Ovarian Neoplasms - pathology
/ Proteins
/ Review
/ Trans-Activators - metabolism
/ Transcription Factors - genetics
/ Transcription Factors - metabolism
/ Tumors
